152 related articles for article (PubMed ID: 12515103)
41. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
42. Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina.
Wu M; Villano A; Russo G; Di Franco A; Stazi A; Lauria C; Sestito A; Lanza GA; Crea F
Cardiology; 2015; 130(4):201-6. PubMed ID: 25790943
[TBL] [Abstract][Full Text] [Related]
43. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
Piscaglia F; Donati G; Gaiani S; Gramantieri L; Leoni S; Mancini M; Bolondi L
Dig Liver Dis; 2004 Sep; 36(9):594-602. PubMed ID: 15460844
[TBL] [Abstract][Full Text] [Related]
44. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
45. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
46. [Lack of tolerance after administration of delayed-action isosorbide-5-mononitrate for 3 days in patients with exercise-induced silent ischemia: control with placebo].
Scardi S; Pandullo C; Humar F; Spanghero M; Mazzone C
G Ital Cardiol; 1992 May; 22(5):549-57. PubMed ID: 1426792
[TBL] [Abstract][Full Text] [Related]
47. Comparison of anti-ischemic effects of isosorbide-5-mononitrate, metoprolol and diltiazem: a study based on serial treadmill exercise test.
Gupta DK; Negi PC; Patial RK; Bansal SK
Indian Heart J; 1995; 47(5):485-8. PubMed ID: 8714503
[TBL] [Abstract][Full Text] [Related]
48. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K
Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999
[TBL] [Abstract][Full Text] [Related]
49. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
[TBL] [Abstract][Full Text] [Related]
51. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
Levine TB; Levine AB; Keteyian SJ; Narins B
Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
[TBL] [Abstract][Full Text] [Related]
52. [Effects of isosorbide-5-mononitrate on clinical condition, bicycle ergometry results, endothelium-dependent vasodilation in patients with ischemic heart disease with stable effort angina].
Kazachkina SS; Balakhonova TV; Lupanov VP; Pogorelova OA; Rogoza AN; Naumov VG
Ter Arkh; 2005; 77(10):71-5. PubMed ID: 16320691
[TBL] [Abstract][Full Text] [Related]
53. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
[TBL] [Abstract][Full Text] [Related]
54. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Silber S
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
[TBL] [Abstract][Full Text] [Related]
55. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Davies RF; Goldberg AD; Forman S; Pepine CJ; Knatterud GL; Geller N; Sopko G; Pratt C; Deanfield J; Conti CR
Circulation; 1997 Apr; 95(8):2037-43. PubMed ID: 9133513
[TBL] [Abstract][Full Text] [Related]
56. Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.
Dogan A; Ozaydin M; Gedikli O; Altinbas A; Ergene O
Jpn Heart J; 2003 Jul; 44(4):463-70. PubMed ID: 12906028
[TBL] [Abstract][Full Text] [Related]
57. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Bolognesi M; Sacerdoti D; Merkel C; Gatta A
J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
[TBL] [Abstract][Full Text] [Related]
58. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study.
Lombardi M; Morales MA; Michelassi C; Moscarelli E; Distante A; L'Abbate A
Eur Heart J; 1993 Jun; 14(6):845-51. PubMed ID: 8325315
[TBL] [Abstract][Full Text] [Related]
60. Isosorbide-5-mononitrate and atenolol in the treatment of stable exertional angina.
Waysbort J; Meshulam N; Brunner D
Cardiology; 1991; 79 Suppl 2():19-26. PubMed ID: 1760824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
